Ozturk, NaileKara, AsliVural, Imran2024-08-042024-08-0420201304-530Xhttps://doi.org/10.4274/tjps.galenos.2019.76402https://search.trdizin.gov.tr/yayin/detay/410561https://hdl.handle.net/11616/92568Objectives: Telmisartan (TLM) is an antihypertensive drug that has been shown to have antiproliferative effects on cancer cells. It has low solubility and suboptimal oral bioavailability. To investigate the potential anticancer effect of TLM on breast cancer cells, poly (D, L-lactide) (PLA) nanoparticles were formulated with the benefit of improving its solubility. Materials and Methods: TLM-loaded PLA nanoparticles were prepared by emulsion solvent evaporation. The effects of sonication time and polymer:drug ratio on nanoparticle size and drug encapsulation were investigated. TLM-loaded nanoparticles were tested against MCF-7 and MDA-MB-231 breast cancer cell lines for antiproliferative effects. Results: Nanoparticles with mean particle size 272 nm and 79% encapsulation efficiency were obtained. Sustained release TLM nanoparticles (40% in 24 h) decreased cell viability to 45% for MCF-7 cells at 72 h, even at the lowest TLM concentration, indicating better anticancer efficiency than TLM solution. Conclusion: TLM nanoparticles could be potential anticancer agents for breast cancer and deserve further studies.eninfo:eu-repo/semantics/openAccessTelmisartannanoparticlesanticancer effectdrug repositioningArticle1754924993317792910.4274/tjps.galenos.2019.764022-s2.0-85094607914Q3410561WOS:000585327200006N/A